(LINE) Lineage, Common Stock - Overview
Sector: Real Estate | Industry: REIT - Industrial | Exchange: NASDAQ (USA) | Market Cap: 10.424m USD | Total Return: -1.1% in 12m
Avg Turnover: 37.4M
Qual. Beats: 0
Rev. Trend: 79.8%
Qual. Beats: 0
Warnings
High Debt/EBITDA (7.3) with thin interest coverage (0.7)
Interest Coverage Ratio 0.7 is critical
Beneish M-Score -1.22 > -1.5 - likely earnings manipulation
Altman Z'' 0.48 < 1.0 - financial distress zone
Choppy
Tailwinds
No distinct edge detected
Lineage, Inc. (LINE) operates as a Real Estate Investment Trust (REIT) specializing in temperature-controlled logistics and storage. The company manages a global network of over 500 facilities across North America, Europe, and the Asia-Pacific region, providing approximately 3.1 billion cubic feet of cold storage capacity.
The business model focuses on industrial real estate optimized for the food and beverage supply chain, integrating cold storage with transportation and technology services. Unlike traditional industrial REITs that lease ambient warehouse space, cold storage providers face higher barriers to entry due to significantly greater initial capital expenditures and specialized power requirements for refrigeration systems.
Lineage provides end-to-end solutions for major global retailers and distributors to reduce food waste and improve distribution efficiency. For a deeper look at the companys valuation metrics, consider exploring the data available on ValueRay. The firm has been incorporated in Maryland since 2015 and currently stands as the worlds largest provider in the temperature-controlled warehouse sector.
- Global food demand stability drives predictable recurring revenue through storage fees
- High energy costs and labor inflation impact net operating income margins
- Expansion of value-added services increases share of wallet across food supply chains
- Interest rate fluctuations significantly affect cost of capital for strategic acquisitions
- Strategic facility locations near major ports mitigate global supply chain disruptions
| Net Income: -146.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.58 > 1.0 |
| NWC/Revenue: -4.24% < 20% (prev -0.28%; Δ -3.95% < -1%) |
| CFO/TA 0.05 > 3% & CFO 934.0m > Net Income -146.0m |
| Net Debt (9.92b) to EBITDA (1.36b): 7.29 < 3 |
| Current Ratio: 0.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (227.0m) vs 12m ago -0.44% < -2% |
| Gross Margin: 11.08% > 18% (prev 32.69%; Δ -21.61% > 0.5%) |
| Asset Turnover: 28.35% > 50% (prev 28.26%; Δ 0.09% > 0%) |
| Interest Coverage Ratio: 0.71 > 6 (EBIT TTM 444.0m / Interest Expense TTM 623.0m) |
| A: -0.01 (Total Current Assets 1.26b - Total Current Liabilities 1.49b) / Total Assets 19.0b |
| B: -0.14 (Retained Earnings -2.61b / Total Assets 19.0b) |
| C: 0.02 (EBIT TTM 444.0m / Avg Total Assets 18.9b) |
| D: 0.81 (Book Value of Equity 8.09b / Total Liabilities 9.99b) |
| Altman-Z'' = 0.48 = B |
| DSRI: 1.07 (Receivables 917.0m/847.0m, Revenue 5.36b/5.30b) |
| GMI: 2.95 (GM 32.69% / 11.08%) |
| AQI: 0.97 (AQ_t 0.25 / AQ_t-1 0.26) |
| SGI: 1.01 (Revenue 5.36b / 5.30b) |
| TATA: -0.06 (NI -146.0m - CFO 934.0m) / TA 19.0b) |
| Beneish M = -1.22 (Cap -4..+1) = D |
As of June 09, 2026, the stock is trading at USD 42.29 with a total of 724,141 shares traded.
Over the past week, the price has changed by -3.95%,
over one month by +5.83%,
over three months by +10.28% and
over the past year by -1.11%.
Lineage, Common Stock has received a consensus analysts rating of 3.63. Therefore, it is recommended to hold LINE.
- StrongBuy: 4
- Buy: 5
- Hold: 9
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 42.2 | -0.3% |
P/E Forward = 769.2308
P/S = 1.9447
P/B = 1.2389
Revenue TTM = 5.36b USD
EBIT TTM = 444.0m USD
EBITDA TTM = 1.36b USD
Long Term Debt = 6.26b USD (from longTermDebt, last quarter)
Short Term Debt = 143.0m USD (from shortTermDebt, last quarter)
Debt = 9.99b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.79b
Net Debt = 9.92b USD (calculated: Debt 9.99b - CCE 67.0m)
Enterprise Value = 20.3b USD (10.4b + Debt 9.99b - CCE 67.0m)
Interest Coverage Ratio = 0.71 (Ebit TTM 444.0m / Interest Expense TTM 623.0m)
EV/FCF = 133.0x (Enterprise Value 20.3b / FCF TTM 153.0m)
FCF Yield = 0.75% (FCF TTM 153.0m / Enterprise Value 20.3b)
FCF Margin = 2.85% (FCF TTM 153.0m / Revenue TTM 5.36b)
Net Margin = -2.72% (Net Income TTM -146.0m / Revenue TTM 5.36b)
Gross Margin = 11.08% ((Revenue TTM 5.36b - Cost of Revenue TTM 4.77b) / Revenue TTM)
Gross Margin QoQ = 14.19% (prev -34.81%)
Tobins Q-Ratio = 1.07 (Enterprise Value 20.3b / Total Assets 19.0b)
Interest Expense / Debt = 6.24% (Interest Expense 623.0m / Debt 9.99b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 350.8m (EBIT 444.0m * (1 - 21.00%))
Current Ratio = 0.85 (Total Current Assets 1.26b / Total Current Liabilities 1.49b)
Debt / Equity = 1.23 (Debt 9.99b / totalStockholderEquity, last quarter 8.09b)
Debt / EBITDA = 7.29 (Net Debt 9.92b / EBITDA 1.36b)
Debt / FCF = 64.84 (Net Debt 9.92b / FCF TTM 153.0m)
Total Stockholder Equity = 8.34b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.77% (Net Income -146.0m / Total Assets 19.0b)
RoE = -1.75% (Net Income TTM -146.0m / Total Stockholder Equity 8.34b)
RoCE = 3.04% (EBIT 444.0m / Capital Employed (Equity 8.34b + L.T.Debt 6.26b))
RoIC = 1.99% (NOPAT 350.8m / Invested Capital 17.6b)
WACC = 6.27% (E(10.4b)/V(20.4b) * Re(7.56%) + D(9.99b)/V(20.4b) * Rd(6.24%) * (1-Tc(0.21)))
Discount Rate = 7.56% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 40.58 | Cagr: 3.41%
[DCF] Terminal Value 77.97% ; FCFF base≈108.6m ; Y1≈124.5m ; Y5≈183.2m
[DCF] Fair Price = N/A (negative equity: EV 2.76b - Net Debt 9.92b = -7.16b; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.29 | # QB: 0
Revenue Correlation: 79.80 | Revenue CAGR: 0.12% | SUE: -0.70 | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.23 | Chg30d=-50.13% | Revisions=-20% | Analysts=2
EPS next Quarter (2026-09-30): EPS=-0.18 | Chg30d=-31.78% | Revisions=-20% | Analysts=2
EPS current Year (2026-12-31): EPS=-0.72 | Chg30d=-3.56% | Revisions=N/A | GrowthEPS=-489.1% | GrowthRev=+0.8%
EPS next Year (2027-12-31): EPS=-0.66 | Chg30d=+13.22% | Revisions=+20% | GrowthEPS=+9.6% | GrowthRev=+3.2%
[Analyst] Revisions Ratio: -20%